Therefore, this study aimed to investigate the prevalence of germline mutations in BRCA1 and BRCA2 genes among women with high-grade serous ovarian cancer (HGSOC) treated in the Public Health System in Recife, Pernambuco. The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.